Cargando…
Subarachnoid hemorrhage: management considerations for COVID-19
Subarachnoid hemorrhage (SAH) has deleterious outcomes for patients, and during the hospital stay, patients are susceptible to vasospasm and delayed cerebral ischemia. Coronavirus disease 2019 (COVID-19) has been shown to worsen hypertension through angiotensin-converting enzyme 2 (ACE2) activity, t...
Autores principales: | Panther, Eric J., Lucke-Wold, Brandon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951071/ https://www.ncbi.nlm.nih.gov/pubmed/35340712 http://dx.doi.org/10.37349/ent.2022.00018 |
Ejemplares similares
-
CNS Lymphoma: Clinical Pearls and Management
Considerations
por: Michel, Michelot, et al.
Publicado: (2022) -
Cytokines and subarachnoid hemorrhage
por: Ruchika, FNU, et al.
Publicado: (2023) -
Exploration of treatments for subarachnoid hemorrhage
por: Hosseini Siyanaki, Mohammad Reza, et al.
Publicado: (2022) -
The glymphatic system and subarachnoid hemorrhage: disruption and recovery
por: Quintin, Stephan, et al.
Publicado: (2022) -
Neuroinflammation and subarachnoid hemorrhage: a revised look at the literature
por: Sriram, Sai, et al.
Publicado: (2022)